Among patients with renal cell carcinoma, those with larger tumors may yield the most benefit from SBRT compared with other ...
Amivantamab with carboplatin and pemetrexed for untreated EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer [ID5110] Draft guidance Technology appraisal guidance 27 March ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback